Granite Shares Advisors LLC Bristol Myers Squibb CO Transaction History

Granite Shares Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $10,129 - $11,247	-159 Reduced 2.49%	6,229 $398,000
Q1 2023 Apr 24, 2023	SELL	$65.71 - $74.53 $6,636 - $7,527	-101 Reduced 1.56%	6,388 $442,000
Q4 2022 Jan 26, 2023	SELL	$68.48 - $81.09 $94,981 - $112,471	-1,387 Reduced 17.61%	6,489 $0
Q3 2022 Oct 14, 2022	SELL	$0.13 - $76.84 $72 - $42,876	-558 Reduced 6.62%	7,876 $559,000
Q2 2022 Jul 22, 2022	SELL	$72.62 - $79.98 $103,701 - $114,211	-1,428 Reduced 14.48%	8,434 $649,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $61,910 - $74,236	-1,007 Reduced 9.26%	9,862 $720,000
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $582,904 - $679,529	10,869 New	10,869 $677,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Shares Advisors LLC with notifications on news.